Cargando…

Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations

Paracetamol (acetaminophen) (PAR), caffeine (CAF) and tramadol hydrochloride (TRA) are important drugs widely used for many clinical purposes. Determination of their contents is of the paramount interest. In this respect, a quick, simple and sensitive isocratic RP-HPLC method with photodiode array d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Fernando J., Rodríguez-Cordero, Aida, López, Roberto, Robles, Luis C., Aller, A. Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156741/
https://www.ncbi.nlm.nih.gov/pubmed/34063393
http://dx.doi.org/10.3390/ph14050466
_version_ 1783699518179508224
author Pereira, Fernando J.
Rodríguez-Cordero, Aida
López, Roberto
Robles, Luis C.
Aller, A. Javier
author_facet Pereira, Fernando J.
Rodríguez-Cordero, Aida
López, Roberto
Robles, Luis C.
Aller, A. Javier
author_sort Pereira, Fernando J.
collection PubMed
description Paracetamol (acetaminophen) (PAR), caffeine (CAF) and tramadol hydrochloride (TRA) are important drugs widely used for many clinical purposes. Determination of their contents is of the paramount interest. In this respect, a quick, simple and sensitive isocratic RP-HPLC method with photodiode array detection was developed for the determination of paracetamol, caffeine and tramadol in pharmaceutical formulations. An improved sensitive procedure was also evolved for tramadol using a fluorescence detector system. A C(18) column and a mobile phase constituted by methanol/phosphate were used. LODs were found to be 0.2 μg/mL, 0.1 μg/mL and 0.3 μg/mL for paracetamol, caffeine and tramadol hydrochloride, respectively, using photodiode-array detection. Alternatively, LOD for tramadol decreased to 0.1 μg/mL with the fluorescence detector. Other notable analytical figures of merit include the linear concentration ranges, 0.8–270 μg/mL, 0.4–250 μg/mL and 1.0–300 (0.2–40) μg/mL, for the same ordered analytes (including the fluorescence detector). The proposed method was successfully applied for the quantitative determination of the three drugs in tablet dosage forms.
format Online
Article
Text
id pubmed-8156741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81567412021-05-28 Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations Pereira, Fernando J. Rodríguez-Cordero, Aida López, Roberto Robles, Luis C. Aller, A. Javier Pharmaceuticals (Basel) Article Paracetamol (acetaminophen) (PAR), caffeine (CAF) and tramadol hydrochloride (TRA) are important drugs widely used for many clinical purposes. Determination of their contents is of the paramount interest. In this respect, a quick, simple and sensitive isocratic RP-HPLC method with photodiode array detection was developed for the determination of paracetamol, caffeine and tramadol in pharmaceutical formulations. An improved sensitive procedure was also evolved for tramadol using a fluorescence detector system. A C(18) column and a mobile phase constituted by methanol/phosphate were used. LODs were found to be 0.2 μg/mL, 0.1 μg/mL and 0.3 μg/mL for paracetamol, caffeine and tramadol hydrochloride, respectively, using photodiode-array detection. Alternatively, LOD for tramadol decreased to 0.1 μg/mL with the fluorescence detector. Other notable analytical figures of merit include the linear concentration ranges, 0.8–270 μg/mL, 0.4–250 μg/mL and 1.0–300 (0.2–40) μg/mL, for the same ordered analytes (including the fluorescence detector). The proposed method was successfully applied for the quantitative determination of the three drugs in tablet dosage forms. MDPI 2021-05-15 /pmc/articles/PMC8156741/ /pubmed/34063393 http://dx.doi.org/10.3390/ph14050466 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pereira, Fernando J.
Rodríguez-Cordero, Aida
López, Roberto
Robles, Luis C.
Aller, A. Javier
Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title_full Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title_fullStr Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title_full_unstemmed Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title_short Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations
title_sort development and validation of an rp-hplc-pda method for determination of paracetamol, caffeine and tramadol hydrochloride in pharmaceutical formulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156741/
https://www.ncbi.nlm.nih.gov/pubmed/34063393
http://dx.doi.org/10.3390/ph14050466
work_keys_str_mv AT pereirafernandoj developmentandvalidationofanrphplcpdamethodfordeterminationofparacetamolcaffeineandtramadolhydrochlorideinpharmaceuticalformulations
AT rodriguezcorderoaida developmentandvalidationofanrphplcpdamethodfordeterminationofparacetamolcaffeineandtramadolhydrochlorideinpharmaceuticalformulations
AT lopezroberto developmentandvalidationofanrphplcpdamethodfordeterminationofparacetamolcaffeineandtramadolhydrochlorideinpharmaceuticalformulations
AT roblesluisc developmentandvalidationofanrphplcpdamethodfordeterminationofparacetamolcaffeineandtramadolhydrochlorideinpharmaceuticalformulations
AT allerajavier developmentandvalidationofanrphplcpdamethodfordeterminationofparacetamolcaffeineandtramadolhydrochlorideinpharmaceuticalformulations